Treatment of hyperprolactinemic amenorrhea with pulsatile gonadotropin-releasing hormone therapy.
Pulsatile GnRH therapy has been shown effective in the treatment of infertility associated with hyperprolactinemia by direct action on the pituitary. Gonadotropin secretion was restored in the setting of moderate hyperprolactinemia. GnRH should be considered as a potential alternative to BCPT therapy in this setting.
D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D007231:Infant, Newborn; D007260:Infusion Pumps; D008297:Male; D010062:Ovulation Induction / Q000379:methods*; D010906:Pituitary Hormone-Releasing Hormones / Q000008:administration & dosage*; D011247:Pregnancy; D013997:Time Factors
D010906:Pituitary Hormone-Releasing Hormones